Comorbidities and Burden of COPD: A Population Based Case-Control Study

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Baty, Florent ^a   Putora, Paul Martin ^a   Isenring, Bruno ^b   Blum, Torsten ^c   Brutsche, Martin ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Chest Clinic Heckeshorn   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ALLERGIC ASTHMA; ANALYTICAL PARAMETERS; ANEMIA; ANXIETY DISORDER; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BRONCHIECTASIS; BRONCHOPNEUMONIA; BRONCHUS CANCER; CACHEXIA; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COR PULMONALE; DEPRESSION; DISEASE ASSOCIATION; DYSPNEA; FEMALE; FISHER EXACT TEST; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPONATREMIA; HYPOTHYROIDISM; HYPOVENTILATION; LENGTH OF STAY; LOBAR PNEUMONIA; LUNG CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PLEURA EFFUSION; PNEUMONIA; POLYCYTHEMIA; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PULMONARY HYPERTENSION; RANK SUM TEST; SEASONAL VARIATION; SLEEP DISORDERED BREATHING; STOMATITIS; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; VEIN INSUFFICIENCY; CASE CONTROL STUDY; CLUSTER ANALYSIS; COST OF ILLNESS; NONPARAMETRIC TEST; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICAL MODEL; SWITZERLAND;

CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMORBIDITY; COST OF ILLNESS; HUMANS; LINEAR MODELS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS, NONPARAMETRIC; SWITZERLAND;

EID: 84877855384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063285     Document Type: Article

References (37)

1. Wedzicha JA, (2000) The heterogeneity of chronic obstructive pulmonary disease. Thorax 55: 631-632.
2. Kim SR, Rhee YK, (2010) Overlap Between Asthma and COPD: Where the Two Diseases Converge. Allergy Asthma Immunol Res 2: 209-214.
3. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, et al. (2012) Global Strategy for the Diag nosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med: in press.
4. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, et al. (2012) Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 186: 155-161.
5. Patel AR, Hurst JR, (2011) Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 5: 647-662.
6. Fabbri LM, Luppi F, Beghe B, Rabe KF, (2008) Complex chronic comorbidities of COPD. Eur Respir J 31: 204-212.
7. Barnes PJ, Celli BR, (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33: 1165-1185.
8. Nussbaumer-Ochsner Y, Rabe KF, (2011) Systemic manifestations of COPD. Chest 139: 165-173.
9. Decramer M, Janssens W, Miravitlles M, (2012) Chronic obstructive pulmonary disease. Lancet 379: 1341-1351.
10. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, et al. (2008) COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD 5: 235-256.
11. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, et al. (2010) Percent emphysema, airow obstruction, and impaired left ventricular filling. N Engl J Med 362: 217-227.
12. Katz P, Chen H, Omachi TA, Gregorich SE, Julian L, et al. (2011) The role of physical inactivity in increasing disability among older adults with obstructive airway disease. J Cardiopulm Rehabil Prev 31: 193-197.
13. Hartman JE, Boezen HM, de Greef MH, Bossenbroek L, ten Hacken NH, (2010) Consequences of physical inactivity in chronic obstructive pulmonary disease. Expert Rev Respir Med 4: 735-745.
14. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG, (2012) Inammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186: 982-988.
15. Burgel PR, Mannino D, (2012) Systemic inammation in patients with chronic obstructive pulmonary disease: one size no longer fits all! Am J Respir Crit Care Med. 186: 936-937.
16. Calverley PM, Scott S, (2006) Is airway inammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? COPD 3: 233-242.
17. van Eeden SF, Sin DD, (2008) Chronic obstructive pulmonary disease: a chronic systemic inammatory disease. Respiration 75: 224-238.
18. Fabbri LM, Rabe KF, (2007) From COPD to chronic systemic inammatory syndrome? Lancet 370: 797-799.
19. Murray CJ, Lopez AD, (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504.
20. van Zyl Smit RN, Pai M, Yew WW, Leung CC, Zumla A, et al. (2010) Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD. Eur Respir J 35: 27-33.
21. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
22. Mannino DM, Buist AS, (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765-773.
23. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ, (2006) Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 43: 75-80.
24. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, et al. (2007) Definition, epidemiology and natural history of COPD. Eur Respir J 30: 993-1013.
25. Pena VS, Miravitlles M, Gabriel R, Jimenez-Ruiz CA, Villasante C, et al. (2000) Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epi demiological study. Chest 118: 981-989.
26. Thomsen RW, Lange P, Hellquist B, Frausing E, Bartels PD, et al. (2011) Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med 105: 1063-1068.
27. Hansell AL, Walk JA, Soriano JB, (2003) What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 22: 809-814.
28. Mannino DM, Thorn D, Swensen A, Holguin F, (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32: 962-969.
29. Lindberg A, Larsson LG, Muellerova H, Ronmark E, Lundback B, (2012) Up-to-date on mortality in COPD- report from the OLIN COPD study. BMC Pulm Med 12: 1.
30. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The body-mass index, airow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012.
31. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
32. R Development Core Team (2012) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org/. ISBN 3-900051-07-0. Accessed 2013 Apr.
33. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
34. Oksanen J (2010) Multivariate analysis of ecological communities in R: vegan tutorial. Available: http://cc.oulu.fi/jarioksa/opetus/metodi/vegantutor.pdf. Accessed 2013 Apr 8.
35. Greenacre M (2010) Biplots in Practice. Fundación BBVA. Available: http://books.google.ch/books?id=dv4LrFP7U EC. Accessed 2013 Apr 8.
36. Culhane AC, Perriere G, Considine EC, Cotter TG, Higgins DG, (2002) Between-group analysis of microarray data. Bioinformatics 18: 1600-1608.
37. Baty F, Facompre M, Wiegand J, Schwager J, Brutsche MH, (2006) Analysis with respect to instrumental variables for the exploration of microarray data structures. BMC Bioinformatics 7: 422.